RPTX

Repare Therapeutics Inc.

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

RPTX price

Repare Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RPTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals RPTX

Valuation

P/E

0.00

Sector -3.50

Industry -3.50

P/BV

0.00

Sector 2.01

Industry 2.01

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

312.78

Sector -223.67

Industry -223.67

EV/EBIT

261.86

Sector -47.92

Industry -47.92

P/EBITDA

Sector -21.50

Industry -21.50

P/EBIT

Sector -28.21

Industry -28.21

P/Total Assets

Sector 1.19

Industry 1.19

P/Net Current Assets

0.00

Sector -10.26

Industry -10.26

P/Working Capital

0.00

Sector -167.98

Industry -167.98

EPS

-1.68

Sector -1.79

Industry -1.79

BVPS

2.68

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

100.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-3.10%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-3.70%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.09

Sector 0.02

Industry 0.02

Profitability

ROE

-62.70%

Sector -56.67%

Industry -56.67%

ROA

-56.95%

Sector -59.91%

Industry -59.91%

ROIC

-21.54%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

10.71

Sector 2.89

Industry 2.89

Net Debt / EBITDA

312.78

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

261.86

Sector -8.06

Industry -8.06

Net Debt / Equity

-0.98

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.91

Sector 0.46

Industry 0.46

Liabilities/Assets

0.09

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

9.33%

Sector -

Industry -

5Y Earnings CAGR

-7.55%

Sector -

Industry -

Fundamentals RPTX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
RPTX Repare Therapeutics Inc.	$0.00	-100.00%	0.00%	0.00	0.00	-62.70%	-100.00%
JNJ Johnson & Johnson	$271.93	57.84%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.65	23.17%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$264.76	22.81%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$39.68	-32.15%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$149.06	90.05%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$167.85	11.92%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.04	48.15%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$71.34	-50.16%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$392.19	41.20%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$793.57	34.58%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$112.35	44.39%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$887.18	27.70%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$513.09	33.92%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$225.92	52.94%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$996.86	35.30%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$41.98	29.01%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RPTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Repare Therapeutics

Repare Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

10 years

Founded: 2016

2020

Time since IPO - 6 years

102

Employees

Repare Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $115.13 million.

The company employs approximately 102 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Repare Therapeutics Inc. reported $11.87 million in revenue, generating net income of $-72.19 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RPTX.

Market cap

Net worth

$115.13 million

$115,130,000.00

Assets

$126.75 million

$126,750,000.00

Total Shares Outstanding

43.00 million

43,000,000

Average Daily Trading Volume

$1.34 million

$1,338,153.76

Sector

Health Care

Industry

Biotechnology

RPTX

RPTX revenue and profits

Financial Results RPTX

DRAG THE FRAME TO SEE MORE DATA

RPTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$887.18 27,70% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$225.92 52,94% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$271.93 57,84% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$264.76 22,81% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$149.06 90,05% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$167.85 10,16% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.65 23,17% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$887.18 27,70% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$225.92 52,94% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$271.93 57,84% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$264.76 22,81% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$149.06 90,05% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$167.85 10,16% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.65 23,17% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Repare Therapeutics (RPTX) today?

A cotação de Repare Therapeutics (RPTX) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Repare Therapeutics (RPTX) iniciou o ano negociando na casa dos US$ 2.60 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Repare Therapeutics (RPTX) e dados de ações do Ibovespa e mercados internacionais.

Quando Repare Therapeutics (RPTX) paga dividendos?

Repare Therapeutics (RPTX) não distribuiu dividendos no último ano.

Is Repare Therapeutics (RPTX) a good investment?

Atualmente, Repare Therapeutics (RPTX) está cotada a US$ 0.00, com um P/L de 0.00, representando um desvio de -628% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Repare Therapeutics (RPTX) stock?

Investir em ações de Repare Therapeutics (RPTX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Repare Therapeutics (RPTX) yield today?

A rentabilidade de Repare Therapeutics (RPTX) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Repare Therapeutics (RPTX) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RPTX

Repare Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RPTX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING RPTX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Repare Therapeutics

Repare Therapeutics Inc.

United States

10 years

2020

102

PROFIT X PRICE RPTX

Financial Results RPTX

RPTX cash flow

Asset, Revenue and Profit Growth - RPTX

RPTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions